These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 1921498)
21. Possible association between eosinophilic fasciitis and subcutaneous heparin use. Cantini F; Salvarani C; Olivieri I; Padula A; Senesi C; Bellandi F; Truglia MC; Niccoli L; Palchetti R J Rheumatol; 1998 Feb; 25(2):383-5. PubMed ID: 9489839 [TBL] [Abstract][Full Text] [Related]
22. Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: a spectrum of sclerodermatous skin disease. Kaufman LD; Seidman RJ; Phillips ME; Gruber BL J Am Acad Dermatol; 1990 Dec; 23(6 Pt 1):1063-9. PubMed ID: 2273104 [TBL] [Abstract][Full Text] [Related]
23. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use. Varga J; Griffin R; Newman JH; Jimenez SA J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221 [TBL] [Abstract][Full Text] [Related]
24. Scleroderma and L-tryptophan: a possible explanation of the eosinophilia-myalgia syndrome. Connolly SM; Quimby SR; Griffing WL; Winkelmann RK J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):451-7. PubMed ID: 2212143 [TBL] [Abstract][Full Text] [Related]
25. Case 4-1990: eosinophilic fasciitis. Gorn A N Engl J Med; 1990 Mar; 322(13):931. PubMed ID: 2314428 [No Abstract] [Full Text] [Related]
26. Is the L-tryptophan metabolite quinolinic acid responsible for eosinophilic fasciitis? Noakes R; Spelman L; Williamson R Clin Exp Med; 2006 Jun; 6(2):60-4. PubMed ID: 16820992 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the pathology of fascia in eosinophilic myalgia syndrome patients and idiopathic eosinophilic fasciitis. Umbert I; Winkelmann RK; Wegener L Dermatology; 1993; 186(1):18-22. PubMed ID: 8435512 [TBL] [Abstract][Full Text] [Related]
31. [Contribution of MRI in the evaluation of fasciitis with eosinophilia induced by L-tryptophan. Apropos of 3 new cases]. Montane de la Roque P; Laroche M; Arlet P; Massip P; Rousseau H; Blain F; Juchet H; Duffaut M; le Tallec Y Rev Rhum Mal Osteoartic; 1991 Dec; 58(12):887-9. PubMed ID: 1780671 [No Abstract] [Full Text] [Related]
33. Eosinophilia-myalgia syndrome associated with L-tryptophan use. Montanaro A; Wakefield D Med J Aust; 1990 Oct; 153(8):491-3. PubMed ID: 2215340 [TBL] [Abstract][Full Text] [Related]
34. Eosinophilic fasciitis occurring under treatment with natalizumab for multiple sclerosis. Bujold J; Boivin C; Amin M; Bouchard JP; Soucy J J Cutan Med Surg; 2014; 18(1):69-71. PubMed ID: 24377479 [TBL] [Abstract][Full Text] [Related]
35. Forearm compartment syndrome as a result of eosinophilic fasciitis: case report. Alolabi B; Lesieur M; Smilovici B; Koo K; El Bahtimi R; Jenkinson RJ J Hand Surg Am; 2015 Apr; 40(4):707-10. PubMed ID: 25747740 [TBL] [Abstract][Full Text] [Related]
36. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique. Shapiro S J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181 [TBL] [Abstract][Full Text] [Related]
37. [Eosinophilia-myalgia syndrome and L-tryptophan intake]. von Gizycki-Nienhaus B; Meurer M; Krieg T; Braun-Falco O Hautarzt; 1991 Mar; 42(3):179-82. PubMed ID: 1829070 [TBL] [Abstract][Full Text] [Related]